SCHEMBL21259065

SCHEMBL21259065

Cc1ccccc1C(=O)Nc1scc(-c2ccccc2)c1C(=O)O

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 11/20 0.73
▸ KMT2A Q03164 11/20 0.73
▸ NPC1 O15118 2/20 0.69
▸ GRIN2C Q14957 1/20 0.62
▸ RAB9A P51151 1/20 0.62
▸ NLRP3 Q96P20 1/20 0.62
▸ PTPN1 P18031 2/20 0.61
▸ PTPRC P08575 1/20 0.61
▸ PTPRF P10586 1/20 0.61
▸ PTPN2 P17706 1/20 0.61
▸ PTPA Q15257 1/20 0.61
▸ PKM P14618 2/20 0.60
▸ USP2 O75604 1/20 0.60
▸ ALDH1A1 P00352 1/20 0.60
▸ TP53 P04637 1/20 0.60
▸ TSHR P16473 1/20 0.60
▸ HTT P42858 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ ANO1 Q5XXA6 4/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12314193 0.94 MEN1 (0.79) MEN1KMT2ANPC1GRIN2CRAB9A
SCHEMBL15503705 0.92 MEN1 (0.68) MEN1KMT2ANPC1RAB9APTPN1
SCHEMBL13901723 0.86 PTPN1 (0.80) MEN1KMT2ARAB9APTPN1PTPRC
SCHEMBL14803202 0.83 MEN1 (0.58) MEN1KMT2ANPC1GRIN2CRAB9A
SCHEMBL21247164 0.82 MEN1 (0.82) MEN1KMT2ANPC1GRIN2CRAB9A
SCHEMBL12314191 0.82 MEN1 (1.00) MEN1KMT2ANPC1GRIN2CRAB9A
SCHEMBL14803701 0.81 ANO1 (0.71) MEN1KMT2AANO1
SCHEMBL21259152 0.79 MEN1 (0.80) MEN1KMT2ANPC1GRIN2CRAB9A
SCHEMBL13926188 0.79 MEN1 (0.88) MEN1KMT2AANO1
SCHEMBL3628774 0.79 CASP3 (0.83) MEN1KMT2ANPC1GRIN2CRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840527-B2 Non-fused thiophene derivatives and their uses ENYO PHARMA (FR) 2023-12-12 — — US disclosed
US-11840527-B2 Non-fused thiophene derivatives and their uses ENYO PHARMA (FR) 2023-12-12 — — US disclosed
US-20200369655-A1 NON-FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO PHARMA (FR) 2020-11-26 — — US disclosed
WO-2019154953-A1 NON-FUSED THIOPHENE DERIVATIVES AND THEIR USES ENYO PHARMA (FR) 2019-08-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369655-A1 NON-FUSED THIOPHENE DERIVATIVES AND THEIR USES FTH1, SLC40A1, FECH MEN1 3578/4885KMT2A 3273/4885NPC1 320/4885
US-11840527-B2 Non-fused thiophene derivatives and their uses FTH1, SLC40A1, FECH MEN1 3578/4885KMT2A 3273/4885NPC1 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback